Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2025-05-21 00:00:00 ET · period of report 2025-05-19 · accession 0001826667-25-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-21 | 2025-05-19 | TLSI | Marshak Richard | Chief Commercial Off | S - Sale | $5.18 | -6,597 | 69.1K | -9% | -$34.2K | |
| 2025-05-21 | 2025-05-19 | TLSI | Marshak Richard | Chief Commercial Off | A - Grant | $5.18 | +21.4K | 75.7K | +39% | +$111.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-19 | S | D | 6,597 | $5.18 | 69,101 | D | — | — | (F2) The sale of the shares was to cover the tax liability associated with the granted RSUs. |
| 2 | Common | Common Stock | 2025-05-19 | A | A | 21,428 | $5.18 | 75,698 | D | — | — | (F1) The granted RSUs vest immediately. |